These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 385712)

  • 21. "Maximum allowable cost" effective date delayed.
    Employee Benefit Plan Rev; 1976 Jun; 30(12):12, 14. PubMed ID: 1037550
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost and price of comparable branded and generic pharmaceuticals.
    Bloom BS; Wierz DJ; Pauly MV
    JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 24. No room for compromise. Bill C-22.
    McGillivray D
    CPJ; 1988 Feb; 121(2):88-9. PubMed ID: 10285967
    [No Abstract]   [Full Text] [Related]  

  • 25. How to pay less for prescription drugs.
    Consum Rep; 1975 Jan; 40(1):48-53. PubMed ID: 1244036
    [No Abstract]   [Full Text] [Related]  

  • 26. Highlights of the Medicare Prescription Drug Act.
    Conomikes GS
    J Okla State Med Assoc; 2005 Oct; 98(10):492-3. PubMed ID: 16296207
    [No Abstract]   [Full Text] [Related]  

  • 27. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perverse incentives in the Medicare prescription drug benefit.
    McAdams D; Schwarz M
    Inquiry; 2007; 44(2):157-66. PubMed ID: 17850042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The irony of drug product selection.
    Wertheimer AI
    Am J Public Health; 1980 May; 70(5):473. PubMed ID: 7377416
    [No Abstract]   [Full Text] [Related]  

  • 30. The MAC program and advisors to the government.
    Shubin S
    Hosp Formul; 1981 Aug; 16(8):869-72, 877-9. PubMed ID: 10252371
    [No Abstract]   [Full Text] [Related]  

  • 31. Prescription drug prices: why do some pay more than others do?
    Frank RG
    Health Aff (Millwood); 2001; 20(2):115-28. PubMed ID: 11260933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 33. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
    Pavenik N
    Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare should bargain for lower drug prices, study says.
    Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacy benefits for Medicare: a "triple-edged" sword.
    Penna P
    Manag Care Interface; 2001 Oct; 14(10):57-8. PubMed ID: 11688094
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Maximum Allowable Cost program--some marketing consequences.
    Gosselin RA
    Med Mark Media; 1978 Feb; 13(2):19-20, 22, 24 passim. PubMed ID: 10306394
    [No Abstract]   [Full Text] [Related]  

  • 39. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states.
    Davis MM; Patel MS; Halasyamani LK
    J Gen Intern Med; 2007 Feb; 22(2):257-63. PubMed ID: 17356996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.